Biotech

Breaking news and analysis on the biotech industry — covering drug development, clinical trials, IPOs, M&A, and the companies pushing biopharma forward.

Biotech

Regeneron posts positive ph. 2 POTS data, eyes pivotal trial

Regeneron has posted positive data on baloncibart in POTS, teeing the biotech up to start a potentially pivotal trial in the first half of 2027.

Nick Paul Taylor Nov 13, 2026 3:31am

ARPA-H bets $4.9 million on ibogaine to treat PTSD in veterans

Nov 12, 2026 2:56pm

Use Kidney Genetics to Strengthen Clinical Trial Design

Brought to you by Natera

Vor pays RemeGen $10M for long-acting autoimmune drug successor

Nov 12, 2026 10:16am

Advanced Analytics Help Reduce Control Animal Use While Preserving Scientific Rigor

How Virtual Control Groups Are Shaping Safety Studies

Brought to you by Charles River Laboratories

Kyverna abandons next-gen CAR-T once touted as miv-cel follow-up

Nov 12, 2026 10:06am